Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-06-09

FDA Approved: PSEUDOEPHEDRINE HCL — Original Application (Better Living Brands LLC)

View source ↗

Summary

FDA approved the original ANDA for pseudoephedrine HCl (Better Living Brands LLC), authorizing its marketing as an over-the-counter nasal decongestant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pseudoephedrine HCl (Pseudoephedrine hydrochloride)

Snippet

ORIG AP for PSEUDOEPHEDRINE HCL (PSEUDOEPHEDRINE HCL)